July 1, 2023 Comments Off on New patent for Abbvie Inc drug RINVOQ Posted in: Patent Added Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. There are seventeen patents…
The post New patent for Abbvie Inc drug RINVOQ appeared first on DrugPatentWat…
July 1, 2023 Comments Off on New patent for Astellas drug CRESEMBA Posted in: Patent Added Annual Drug Patent Expirations for CRESEMBA Cresemba is a drug marketed by Astellas and is included in two NDAs. It is available from one supplier. There are four patents protecting…
The post New patent for Astellas drug CRESEMBA appeared first on Drug…
